AVBP R&D Expense Growth
Arrivent Biopharma Inc · R&D Expense Growth
AVBP R&D Expense Growth
Latest reported94.11%period ending
AVBP FY R&D Growth (YoY) (0.00% → 94.11%)
Latest values, visible window
High-resolution chart · PNG
AVBP r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 94.1054% | |
| 21.7619% | |
| 113.2028% | |
| 373.0028% | |
| 0% |